Additionally, mutations in EGFR downstream signaling pathways, including KRAS, BRAF, and PIK3CA, are crucial for metastatic CRC progression [48], while abnormalities in the JAK2/STAT3 pathway disrupt apoptosis. The gene discussed is STAT3; the disease is colorectal carcinoma.